What are you looking for? Write the name, title or any keyword related to what you are looking for and select which content category it belongs to. Search Fulltext search Activities Professionals Research groups News - Any - Year 2024 Data d'inici Tue, 20 Aug 2024 - 12:00 Data de tancament Tue, 3 Sep 2024 - 12:00 Descripció Biobank Technician_20240298 Codi 2024-298 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0298//2024_0298_001.pdf Reclutant Inactiu Year 2024 Data d'inici Mon, 19 Aug 2024 - 12:00 Data de tancament Mon, 2 Sep 2024 - 12:00 Descripció Software Technician_20240297 Codi 2024-297 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0297//2024_0297_001.pdf Reclutant Inactiu Year 2024 Data d'inici Fri, 16 Aug 2024 - 12:00 Data de tancament Fri, 30 Aug 2024 - 12:00 Descripció Head of Software Development and System & Data architecture_20240296 Codi 2024-296 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0296//2024_0296_001.pdf Reclutant Inactiu Year 2024 Data d'inici Tue, 13 Aug 2024 - 12:00 Data de tancament Tue, 27 Aug 2024 - 12:00 Grup de recerca Reconstructive Surgery of the Locomotor System Descripció Data Manager Septic and Reconstructive Surgery Unit_20240294 Codi 2024-294 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0294//2024_0294_001.pdf Reclutant Inactiu Year 2024 Data d'inici Tue, 13 Aug 2024 - 12:00 Data de tancament Tue, 27 Aug 2024 - 12:00 Grup de recerca Diabetes and Metabolism Descripció Graduate Technician Diabetes and Metabolism Department Codi 2024-295 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0295//2024_0295_001.pdf Reclutant Inactiu Estudio fase II de Avelumab más quimioterapia en el tratamiento perioperatorio de pacientes con carcinoma gástrico (CG) o de la unión gastroesofágica (CUGE) localmente avanzado resecable. Estudio MONEO Contact Protocol code: VHIO19001 EudraCT code: 2019-000782-21 Principal investigator: Acosta Eyzaguirre, Daniel Research group: Recerca biomèdica en tumors de l'aparell digestiu Service: Oncologia Phase: Fase II Recruiting: Open Status: Iniciat Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. A Phase 3, Multinational, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of NTLA-2001 in Participants with Transthyretin Amyloidosis with Cardiomyopathy (ATTR-CM) Contact Protocol code: ITL-2001-CL-301 EudraCT code: No aplica Pathology: Símptomes, signes i troballes anormals clíniques i de laboratori, no classificades enlloc més Principal investigator: Martínez Valle, Fernando Research group: Malalties sistèmiques Service: Medicina Interna Phase: Fase III Recruiting: Open Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Tranexamic acid for hyperacute spontaneous IntraCerebral Haemorrhage (TICH-3). Contact Protocol code: 21022 (TICH-3) EudraCT code: 2021-001050-62 Pathology: Malalties del sistema nerviós Principal investigator: Rodriguez Luna, David Research group: Recerca en ictus Service: Neurologia Phase: Phase III Recruiting: Open Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Ensayo de fase III multicéntrico, aleatorizado, doble ciego, comparativo con placebo, de 48 semanas de duración, para evaluar la eficacia y la seguridad de survodutide administrada por vía subcutánea en participantes con sobrepeso u obesidad y esteatohepatitis no alcohólica (EHNA) presunta o confirmada. Contact Protocol code: 1404-0056 EudraCT code: No aplica Pathology: Symptoms, signs, and abnormal clinical and laboratory findings, not elsewhere classified Principal investigator: Pericàs Pulido, Juan Manuel Research group: Malalties hepàtiques Service: Hepatologia Phase: Phase III Recruiting: Closed Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Un estudio de fase IIb, multicéntrico, aleatorizado, doble ciego, de búsqueda de dosis, para evaluar la eficacia, seguridad y tolerabilidad de balcinrenona en combinación con dapagliflozina en comparación con dapagliflozina en pacientes con enfermedad renal crónica y albuminuria. Contact Protocol code: D6405C00002 EudraCT code: No aplica Pathology: Symptoms, signs, and abnormal clinical and laboratory findings, not elsewhere classified Principal investigator: Soler Romeo, Maria Jose Research group: Nefrologia i trasplantament renal Service: Nefrologia Phase: Phase II Recruiting: Open Status: Tancat Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Estudio de fase 1/3, doble ciego, aleatorizado, con control activo yde grupos paralelos para comparar la eficacia, la farmacocinética, la farmacodinámicay la seguridad de CT-P53 y Ocrevus en pacientes con esclerosis múltiple remitenterecurrente Contact Protocol code: CT-P53 3.1 EudraCT code: No aplica Pathology: Nervous system diseases Principal investigator: Montalban Gairín, Xavier Research group: Neuroimmunologia clínica Service: Neuroimmunologia Phase: Phase III Recruiting: Open Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Ensayo fase III, aleatorizado, doble ciego para evaluar el efecto de balcinrenona/dapagliflozina, en comparación con dapagliflozina, sobre el riesgo de eventos de insuficiencia cardiaca y muerte cardiovascular en pacientes con insuficiencia cardíaca y función renal alterada Contact Protocol code: D6402C00012 EudraCT code: No aplica Pathology: Malalties del sistema circulatori Principal investigator: Méndez Fernández, Ana Belén Research group: Malalties cardiovasculars Service: Cardiologia Phase: Phase III Recruiting: Open Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. ESTUDIO EN FASE IIIB SIN ENMASCARAMIENTO PARA EVALUAR LA EFICACIA Y LA SEGURIDAD DEL TRATAMIENTO CON LEBRIKIZUMAB EN ADULTOS Y ADOLESCENTES CON DERMATITIS ATÓPICA DE MODERADA A GRAVE. Contact Protocol code: M-17923-34 EudraCT code: No aplica Pathology: Tumors Principal investigator: Aparicio Español, Gloria Service: Dermatologia Phase: Phase III Recruiting: Open Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. An Exploratory, Multicenter, Randomized, double-blind, placebo-controlled study evaluating the effect and safety of pitolisant in children and adolescents with Autism Spectrum Disorders. Contact Protocol code: P21-01 EudraCT code: _ Pathology: Trastorns mentals i del comportament Principal investigator: Gisbert Gustemps, Laura Research group: Psiquiatria, salut mental i addiccions Service: Psiquiatria Phase: Phase II Recruiting: Open Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. A Phase 3, Randomized, Double-blind, Placebo-controlled Study of BION-1301 in Adults with IgA Nephropathy Contact Protocol code: CHK02-02 EudraCT code: No aplica Pathology: Symptoms, signs, and abnormal clinical and laboratory findings, not elsewhere classified Principal investigator: Agraz Pamplona, Irene Research group: Nephrology and kidney transplantation Service: Nephrology Phase: Phase III Recruiting: Open Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. A Multi-center, Randomized, Double-blind, Placebo-controlled Trial toEvaluate the Neurological Effects of EryDex on subjects with Ataxia Telangiectasia Contact Protocol code: IEDAT-04-2022 EudraCT code: No aplica Pathology: Nervous system diseases Principal investigator: Gómez Andrés, David Research group: Teràpies i Innovació en Neuropediatria i altres malalties rares pediàtriques Service: Pediatria General i Especialitats Phase: Phase III Recruiting: Open Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. A Phase 2a, Randomised, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of NMD670 Over 21 Days Ambulatory Adult Patients With Type 1 and Type 2 Charcot-Marie-Tooth Disease Contact Protocol code: NMD670-02-0003 EudraCT code: No aplica Pathology: Nervous system diseases Principal investigator: Juntas Morales, Raul Research group: Sistema nerviós perifèric Service: Neurology Phase: Phase II Recruiting: Open Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Effects of NNC0194-0499 alone and in combination with semaglutide, of semaglutide alone, and of cagrilintide alone and in combination with semaglutide on liver damage and alcohol use in people with alcohol-related liver disease Contact Protocol code: NN9500-7730 EudraCT code: No aplica Pathology: Symptoms, signs, and abnormal clinical and laboratory findings, not elsewhere classified Principal investigator: Ventura Cots, Meritxell Research group: Liver Diseases Service: Hepatology Phase: Phase II Recruiting: Open Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect ofEDG-5506 on Safety, Biomarkers, Pharmacokinetics, and Functional Measures in Adults andAdolescents with Becker Muscular Dystrophy Contact Protocol code: EDG-5506-201 EudraCT code: No aplica Pathology: Nervous system diseases Principal investigator: Juntas Morales, Raul Research group: Peripheral Nervous System Service: Neurology Phase: Phase II Recruiting: Open Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Year 2024 Data d'inici Mon, 12 Aug 2024 - 12:00 Data de tancament Mon, 30 Sep 2024 - 12:00 Grup de recerca Microbiology Descripció Project Manager-Microbiology Research Group_20240292 Codi 2024-292 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0292//2024_0292_001.pdf Reclutant Actiu Pagination First page « Previous page ‹ … Page 1419 Page 1420 Current page 1421 Page 1422 Page 1423 … Next page › Last page »
Year 2024 Data d'inici Tue, 20 Aug 2024 - 12:00 Data de tancament Tue, 3 Sep 2024 - 12:00 Descripció Biobank Technician_20240298 Codi 2024-298 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0298//2024_0298_001.pdf Reclutant Inactiu
Year 2024 Data d'inici Mon, 19 Aug 2024 - 12:00 Data de tancament Mon, 2 Sep 2024 - 12:00 Descripció Software Technician_20240297 Codi 2024-297 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0297//2024_0297_001.pdf Reclutant Inactiu
Year 2024 Data d'inici Fri, 16 Aug 2024 - 12:00 Data de tancament Fri, 30 Aug 2024 - 12:00 Descripció Head of Software Development and System & Data architecture_20240296 Codi 2024-296 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0296//2024_0296_001.pdf Reclutant Inactiu
Year 2024 Data d'inici Tue, 13 Aug 2024 - 12:00 Data de tancament Tue, 27 Aug 2024 - 12:00 Grup de recerca Reconstructive Surgery of the Locomotor System Descripció Data Manager Septic and Reconstructive Surgery Unit_20240294 Codi 2024-294 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0294//2024_0294_001.pdf Reclutant Inactiu
Year 2024 Data d'inici Tue, 13 Aug 2024 - 12:00 Data de tancament Tue, 27 Aug 2024 - 12:00 Grup de recerca Diabetes and Metabolism Descripció Graduate Technician Diabetes and Metabolism Department Codi 2024-295 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0295//2024_0295_001.pdf Reclutant Inactiu
Year 2024 Data d'inici Mon, 12 Aug 2024 - 12:00 Data de tancament Mon, 30 Sep 2024 - 12:00 Grup de recerca Microbiology Descripció Project Manager-Microbiology Research Group_20240292 Codi 2024-292 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0292//2024_0292_001.pdf Reclutant Actiu
